intellectual property
US Patent Office Invalidates Two Agilent Technologies Patents Covering CRISPR Guide RNAs
Synthego, an Agilent competitor in the gene editing market, had initiated an inter partes review in January 2022 as part of a plan to ward off patent infringement allegations.
Jury Awards Natera $19.4M in Damages in Invitae, ArcherDx Patent Infringement Suit
A jury determined that Invitae and ArcherDx have infringed three patents and awarded Natera damages for lost profits and past royalties.
Pillar Biosciences Licenses KeyGene NGS IP
The intellectual property relates to the use of a combination of two or more nucleotide sequence identifiers in the preparation of a sample DNA for high-throughput sequencing.
Invitae, OptraHealth Resolve Chatbot Patent Dispute
OptraHealth will license its automated genetic test result retrieval and return process to Invitae, while both companies continue to offer their own products.
Critics of the bill suggested that it would allow patents on pathogen genetic material, which could hamper the ability to test and treat in future pandemics.